Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • iSpecimen's Cost of Revenue fell 2659.04% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 3402.37%. This contributed to the annual value of $5.3 million for FY2024, which is 1000.87% up from last year.
  • As of Q3 2025, iSpecimen's Cost of Revenue stood at $1.1 million, which was down 2659.04% from $444177.0 recorded in Q2 2025.
  • iSpecimen's 5-year Cost of Revenue high stood at $1.6 million for Q1 2021, and its period low was $444177.0 during Q2 2025.
  • Over the past 5 years, iSpecimen's median Cost of Revenue value was $1.2 million (recorded in 2022), while the average stood at $1.2 million.
  • As far as peak fluctuations go, iSpecimen's Cost of Revenue soared by 21418.83% in 2021, and later crashed by 6881.64% in 2025.
  • iSpecimen's Cost of Revenue (Quarter) stood at $1.2 million in 2021, then grew by 15.32% to $1.4 million in 2022, then rose by 1.25% to $1.4 million in 2023, then fell by 7.22% to $1.3 million in 2024, then dropped by 13.84% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $444177.0 for Q2 2025, and $657279.0 during Q1 2025.